Professor | Yiqiao Xing | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Yiqiao Xing

Contact Information

yiqiao_xing57@whu.edu.cn

Language ability

English, Chinese, German

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1978-1982 Bachelor of Clinical Medicine: Hubei Medical College (now Wuhan University Medical Department) 1986-1989 Master's Degree: Hubei Medical College (now Wuhan University Medical Department) 1994-1996 PhD: Philipps University of Marburg Hosted 3 National Natural Science Foundation projects, multiple provincial and national key projects
Work Experience	1982-1986 Resident Physician, Ophthalmology, Renmin Hospital of Wuhan University 1986-1994 Attending Physician, Ophthalmology, Renmin Hospital of Wuhan University 1996-2001 Associate Chief Physician, Associate Professor, Ophthalmology, Renmin Hospital of Wuhan University 2001-2002 Chief Physician, Ophthalmology, Renmin Hospital of Wuhan University 2002-present Professor, Ophthalmology, Renmin Hospital of Wuhan University 2004-present Doctoral Supervisor, Renmin Hospital of Wuhan University
Awards	Huaxia Medical Science and Technology Award, Third Prize Hubei Province Science and Technology Progress Second Prize: Research on the application of Triamcinolone in vitreoretinal diseases Hubei Province Science and Technology Progress Third Prize: Basic and clinical research on retinopathy of prematurity Outstanding Doctoral Dissertation Supervisor in Hubei Province

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1978-1982 Bachelor of Clinical Medicine: Hubei Medical College (now Wuhan University Medical Department)
1986-1989 Master's Degree: Hubei Medical College (now Wuhan University Medical Department)
1994-1996 PhD: Philipps University of Marburg
Hosted 3 National Natural Science Foundation projects, multiple provincial and national key projects

Work Experience

1982-1986 Resident Physician, Ophthalmology, Renmin Hospital of Wuhan University
1986-1994 Attending Physician, Ophthalmology, Renmin Hospital of Wuhan University
1996-2001 Associate Chief Physician, Associate Professor, Ophthalmology, Renmin Hospital of Wuhan University
2001-2002 Chief Physician, Ophthalmology, Renmin Hospital of Wuhan University
2002-present Professor, Ophthalmology, Renmin Hospital of Wuhan University
2004-present Doctoral Supervisor, Renmin Hospital of Wuhan University

Awards

Huaxia Medical Science and Technology Award, Third Prize
Hubei Province Science and Technology Progress Second Prize: Research on the application of Triamcinolone in vitreoretinal diseases
Hubei Province Science and Technology Progress Third Prize: Basic and clinical research on retinopathy of prematurity
Outstanding Doctoral Dissertation Supervisor in Hubei Province

Areas of Focus	Vitreoretinal Diseases Cataract
Publications	CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway, Zeng S, Du L, Lu G, Xing Y, 2023 Galectin-1-dependent ceRNA network in HRMECs revealed its association with retinal neovascularization, Yang N, Zhang N, Wang Z, Cao W, He X, Zhang W, Xing Y, 2023 Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis, He X, Cao W, Wang Z, Zhang N, Xu K, Yu L, Xing Y, Yang N, 2023 A literature-derived dataset on risk factors for dry eye disease, Yang W, Yang K, Pan Y, Wu S, Chen X, Shen L, Zeng Q, Wu J, Lv M, Zhang Jm Yang Y, Xing Y, 2023 Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus, Guo X, Xing Y, Jin W*, 2023

Areas of Focus

Vitreoretinal Diseases
Cataract

Publications

CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway, Zeng S, Du L, Lu G, Xing Y*, 2023
Galectin-1-dependent ceRNA network in HRMECs revealed its association with retinal neovascularization, Yang N, Zhang N, Wang Z, Cao W, He X, Zhang W*, Xing Y*, 2023
Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis, He X, Cao W, Wang Z, Zhang N, Xu K, Yu L, Xing Y*, Yang N*, 2023
A literature-derived dataset on risk factors for dry eye disease, Yang W, Yang K, Pan Y, Wu S, Chen X, Shen L, Zeng Q, Wu J, Lv M, Zhang Jm Yang Y*, Xing Y*, 2023
Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus, Guo X, Xing Y*, Jin W*, 2023

Vitreoretinal Diseases Clinical Research Cataract Surgery Ophthalmology Treatment Retinal Therapy Lens Implantation Visual Acuity Eye

Ke Min - Wuhan University

Xiaojun Cai - Wuhan University

Zeng Wen - Wuhan University

View All

Personal Information